成田キャンパス
皮膚科学教室

皮膚科学教室

教室紹介

業績 2021年

英文論文

  1. Ansai SI, Umebayashi Y, Katsumata N, Kato H, Kadono T, Takai T, Namiki T, Nakagawa M, Soejima T, Koga H, Sugaya M. 2021. Japanese Dermatological Association Guidelines: Outlines of Guidelines for Cutaneous Squamous Cell Carcinoma 2020. J Dermatol 48:e288-e311.
  2. Hasui KI, Ide M, Hamada T. 2021. An intermittent red-purple rash after shopping in the fresh food section. Int J Dermatol 60:39-40.
  3. Hisamoto T, Suga H, Kawana Y, Oka T, Miyagaki T, Sugaya M, Sato S. 2021. A case of mycosis fungoides successfully treated with combination of bexarotene and mogamulizumab. Dermatol Ther 34:e14805.
  4. Kawana Y, Suga H, Kamijo H, Miyagaki T, Sugaya M, Sato S. 2021. Roles of OX40 and OX40 Ligand in Mycosis Fungoides and Sézary Syndrome. Int J Mol Sci 22.
  5. Morimura S, Sugaya M, Oka T, Suga H, Miyagaki T, Tsunemi Y, Asano Y, Sato S. 2021. Increased Regulatory T Cells and Decreased Myeloid-Derived Suppressor Cells Induced by High CCL17 Levels May Account for Normal Incidence of Cancers among Patients with Atopic Dermatitis. Int J Mol Sci 22.
  6. Ohtsuka M, Hamada T, Miyagaki T, Shimauchi T, Yonekura K, Kiyohara E, Fujita H, Izutsu K, Okuma K, Kawai K, Koga H, Sugaya M. 2021. Outlines of the Japanese guidelines for the management of primary cutaneous lymphomas 2020. J Dermatol 48:e49-e71.
  7. Ouchi T, Morimura S, Dow LE, Miyoshi H, Udey MC. 2021. EpCAM (CD326) Regulates Intestinal Epithelial Integrity and Stem Cells via Rho-Associated Kinase. Cells 10.
  8. Sakamoto M, Miyagaki T, Kamijo H, Oka T, Boki H, Takahashi-Shishido N, Suga H, Sugaya M, Sato S. 2021. CD147-Cyclophilin a Interactions Promote Proliferation and Survival of Cutaneous T-Cell Lymphoma. Int J Mol Sci 22.
  9. Senda N, Yanai H, Hibino S, Li L, Mizushima Y, Miyagaki T, Saeki M, Kishi Y, Hangai S, Nishio J, Sugaya M, Taniguchi T, Sato S. 2021. HMGB1-mediated chromatin remodeling attenuates Il24 gene expression for the protection from allergic contact dermatitis. Proc Natl Acad Sci U S A 118.
  10. Sugaya M. 2021. Is blocking IL-4 receptor alpha beneficial for patients with mycosis fungoides or Sézary syndrome? J Dermatol 48:e225-e226.
  11. Sugaya M, Funamizu K, Kono M, Okuno Y, Kondo T, Ono R, Akiyama M, Nishigori C, Sato S. 2021. Whole-exome sequencing and host cell reactivation assay lead to a diagnosis of xeroderma pigmentosum group D with mild ultraviolet radiation sensitivity. J Dermatol 48:96-100.
  12. Sugaya M, Ishii M, Takahashi-Shishido N, Ichimura Y, Morimura S. 2021. Case of bullous pemphigoid under treatment with adalimumab for hidradenitis suppurativa. J Dermatol 48:e163-e164.
  13. Sumida H, Migita K, Ida H, Asano Y, Shimizu J, Kagami S, Sugaya M, Kadono T, Sato S. 2021. Dermatomyositis-like eruptions and fasciitis with novel compound heterozygous MEFV mutations: Newly recognized features of a variant of familial Mediterranean fever. J Dermatol 48:1453-1456.
  14. Takahashi-Shishido N, Sugaya M, Morimura S, Suga H, Oka T, Kamijo H, Miyagaki T, Sato S. 2021. Mycosis fungoides and Sézary syndrome tumor cells express epidermal fatty acid-binding protein, whose expression decreases with loss of epidermotropism. J Dermatol 48:685-689.